172 related articles for article (PubMed ID: 24337603)
1. A comparison of the behavior of (64)Cu-acetate and (64)Cu-ATSM in vitro and in vivo.
Hueting R; Kersemans V; Cornelissen B; Tredwell M; Hussien K; Christlieb M; Gee AD; Passchier J; Smart SC; Dilworth JR; Gouverneur V; Muschel RJ
J Nucl Med; 2014 Jan; 55(1):128-34. PubMed ID: 24337603
[TBL] [Abstract][Full Text] [Related]
2. Intertumoral differences in hypoxia selectivity of the PET imaging agent 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone).
Yuan H; Schroeder T; Bowsher JE; Hedlund LW; Wong T; Dewhirst MW
J Nucl Med; 2006 Jun; 47(6):989-98. PubMed ID: 16741309
[TBL] [Abstract][Full Text] [Related]
3. 64Cu-ATSM Reflects pO2 Levels in Human Head and Neck Cancer Xenografts but Not in Colorectal Cancer Xenografts: Comparison with 64CuCl2.
Li F; Jørgensen JT; Forman J; Hansen AE; Kjaer A
J Nucl Med; 2016 Mar; 57(3):437-43. PubMed ID: 26585061
[TBL] [Abstract][Full Text] [Related]
4. Nitroimidazole conjugates of bis(thiosemicarbazonato)64Cu(II) - Potential combination agents for the PET imaging of hypoxia.
Bonnitcha PD; Bayly SR; Theobald MB; Betts HM; Lewis JS; Dilworth JR
J Inorg Biochem; 2010 Feb; 104(2):126-35. PubMed ID: 19932509
[TBL] [Abstract][Full Text] [Related]
5. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer.
Valtorta S; Belloli S; Sanvito F; Masiello V; Di Grigoli G; Monterisi C; Fazio F; Picchio M; Moresco RM
J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model.
Lewis JS; McCarthy DW; McCarthy TJ; Fujibayashi Y; Welch MJ
J Nucl Med; 1999 Jan; 40(1):177-83. PubMed ID: 9935074
[TBL] [Abstract][Full Text] [Related]
7. Monitoring the effect of mild hyperthermia on tumour hypoxia by Cu-ATSM PET scanning.
Myerson RJ; Singh AK; Bigott HM; Cha B; Engelbach JA; Kim J; Lamoreaux WT; Moros E; Novak P; Sharp TL; Straube W; Welch MJ; Xu M
Int J Hyperthermia; 2006 Mar; 22(2):93-115. PubMed ID: 16754595
[TBL] [Abstract][Full Text] [Related]
8. Delineation of hypoxia in canine myocardium using PET and copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone).
Lewis JS; Herrero P; Sharp TL; Engelbach JA; Fujibayashi Y; Laforest R; Kovacs A; Gropler RJ; Welch MJ
J Nucl Med; 2002 Nov; 43(11):1557-69. PubMed ID: 12411560
[TBL] [Abstract][Full Text] [Related]
9. Internal radiotherapy with copper-64-diacetyl-bis (N4-methylthiosemicarbazone) reduces CD133+ highly tumorigenic cells and metastatic ability of mouse colon carcinoma.
Yoshii Y; Furukawa T; Kiyono Y; Watanabe R; Mori T; Yoshii H; Asai T; Okazawa H; Welch MJ; Fujibayashi Y
Nucl Med Biol; 2011 Feb; 38(2):151-7. PubMed ID: 21315269
[TBL] [Abstract][Full Text] [Related]
10. Cardiac hypoxia imaging: second-generation analogues of 64Cu-ATSM.
Handley MG; Medina RA; Mariotti E; Kenny GD; Shaw KP; Yan R; Eykyn TR; Blower PJ; Southworth R
J Nucl Med; 2014 Mar; 55(3):488-94. PubMed ID: 24421288
[TBL] [Abstract][Full Text] [Related]
11. Tumor uptake of copper-diacetyl-bis(N(4)-methylthiosemicarbazone): effect of changes in tissue oxygenation.
Lewis JS; Sharp TL; Laforest R; Fujibayashi Y; Welch MJ
J Nucl Med; 2001 Apr; 42(4):655-61. PubMed ID: 11337556
[TBL] [Abstract][Full Text] [Related]
12. The influence of tumor oxygenation on hypoxia imaging in murine squamous cell carcinoma using [64Cu]Cu-ATSM or [18F]Fluoromisonidazole positron emission tomography.
Matsumoto K; Szajek L; Krishna MC; Cook JA; Seidel J; Grimes K; Carson J; Sowers AL; English S; Green MV; Bacharach SL; Eckelman WC; Mitchell JB
Int J Oncol; 2007 Apr; 30(4):873-81. PubMed ID: 17332926
[TBL] [Abstract][Full Text] [Related]
13. (64)Cu-ATSM therapy targets regions with activated DNA repair and enrichment of CD133(+) cells in an HT-29 tumor model: Sensitization with a nucleic acid antimetabolite.
Yoshii Y; Furukawa T; Matsumoto H; Yoshimoto M; Kiyono Y; Zhang MR; Fujibayashi Y; Saga T
Cancer Lett; 2016 Jun; 376(1):74-82. PubMed ID: 26996296
[TBL] [Abstract][Full Text] [Related]
14. Alteration of Cellular Reduction Potential Will Change
Floberg JM; Wang L; Bandara N; Rashmi R; Mpoy C; Garbow JR; Rogers BE; Patti GJ; Schwarz JK
J Nucl Med; 2020 Mar; 61(3):427-432. PubMed ID: 31586008
[TBL] [Abstract][Full Text] [Related]
15. A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers.
Carlin S; Zhang H; Reese M; Ramos NN; Chen Q; Ricketts SA
J Nucl Med; 2014 Mar; 55(3):515-21. PubMed ID: 24491409
[TBL] [Abstract][Full Text] [Related]
16. Paired 18F-Fluorodeoxyglucose (18F-FDG), and 64Cu-Copper(II)-diacetyl-bis(N(4)-methylthiosemicarbazone) (64Cu-ATSM) PET Scans in Dogs with Spontaneous Tumors and Evaluation for Hypoxia-Directed Therapy.
Maitz CA; Tate D; Bechtel S; Lunceford J; Henry C; Flesner B; Collins A; Varterasian M; Tung D; Zhang L; Saha S; Bryan JN
Radiat Res; 2022 Mar; 197(3):253-260. PubMed ID: 34855934
[TBL] [Abstract][Full Text] [Related]
17. A limited overlap between intratumoral distribution of 1-(5-fluoro-5-deoxy-α-D-arabinofuranosyl)-2-nitroimidazole and copper-diacetyl-bis[N(4)-methylthiosemicarbazone].
Furukawa T; Yuan Q; Jin ZH; Aung W; Yoshii Y; Hasegawa S; Endo H; Inoue M; Zhang MR; Fujibayashi Y; Saga T
Oncol Rep; 2015 Sep; 34(3):1379-87. PubMed ID: 26134305
[TBL] [Abstract][Full Text] [Related]
18. A dual radiolabelling approach for tracking metal complexes: investigating the speciation of copper bis(thiosemicarbazonates) in vitro and in vivo.
Hueting R; Kersemans V; Tredwell M; Cornelissen B; Christlieb M; Gee AD; Passchier J; Smart SC; Gouverneur V; Muschel RJ; Dilworth JR
Metallomics; 2015 May; 7(5):795-804. PubMed ID: 25768310
[TBL] [Abstract][Full Text] [Related]
19. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
O'Donoghue JA; Zanzonico P; Pugachev A; Wen B; Smith-Jones P; Cai S; Burnazi E; Finn RD; Burgman P; Ruan S; Lewis JS; Welch MJ; Ling CC; Humm JL
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1493-502. PubMed ID: 15817355
[TBL] [Abstract][Full Text] [Related]
20. Cellular Uptake of the ATSM-Cu(II) Complex under Hypoxic Conditions.
Walke GR; Meron S; Shenberger Y; Gevorkyan-Airapetov L; Ruthstein S
ChemistryOpen; 2021 Apr; 10(4):486-492. PubMed ID: 33908707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
